HONLIV HEALTH (09906) Income Statement & Earnings

1.560
0.0000.00%

Not Open Apr 24 09:20 CST

936.00MMarket Cap82.11P/E (TTM)

HONLIV HEALTH (09906) Income Statement

All

YOY

Hide blank lines

(Q6)Jun 30, 2025

(FY)Dec 31, 2024

(Q6)Jun 30, 2024

(FY)Dec 31, 2023

(Q6)Jun 30, 2023

(FY)Dec 31, 2022

(Q6)Jun 30, 2022

(FY)Dec 31, 2021

(Q6)Jun 30, 2021

(FY)Dec 31, 2020

Turnover

-16.46%346.82M

1.08%768.73M

12.07%415.18M

4.50%760.53M

-1.14%370.47M

19.93%727.79M

30.84%374.74M

15.80%606.84M

17.07%286.4M

-1.33%524.04M

Operating income

-16.46%346.82M

1.08%768.73M

12.07%415.18M

4.50%760.53M

-1.14%370.47M

19.93%727.79M

30.84%374.74M

15.80%606.84M

17.07%286.4M

-1.33%524.04M

Cost of sales

12.38%-301.02M

-4.28%-642.03M

-14.32%-343.56M

-4.46%-615.68M

-3.21%-300.52M

-25.00%-589.39M

-33.11%-291.17M

-22.02%-471.53M

-19.60%-218.74M

-7.06%-386.45M

Operating expenses

12.38%-301.02M

-4.28%-642.03M

-14.32%-343.56M

-4.46%-615.68M

-3.21%-300.52M

-25.00%-589.39M

-33.11%-291.17M

-22.02%-471.53M

-19.60%-218.74M

-7.06%-386.45M

Gross profit

-36.05%45.8M

-12.53%126.69M

2.39%71.62M

4.66%144.84M

-16.30%69.95M

2.28%138.4M

23.51%83.57M

-1.66%135.31M

9.55%67.67M

-19.14%137.59M

Administrative expenses

-8.34%-41.91M

-5.51%-76.38M

-4.76%-38.69M

1.30%-72.39M

-4.91%-36.93M

-7.00%-73.35M

-7.93%-35.21M

3.73%-68.55M

10.68%-32.62M

3.92%-71.2M

Impairment and provision

165.31%209K

96.53%-530K

-147.34%-320K

-679.11%-15.29M

110.16%676K

-2,209.41%-1.96M

---6.65M

98.16%-85K

----

-18,340.00%-4.61M

-Other impairment is provision

165.31%209K

96.53%-530K

-147.34%-320K

-679.11%-15.29M

110.16%676K

-2,209.41%-1.96M

---6.65M

98.16%-85K

----

-18,340.00%-4.61M

Special items of operating profit

22.08%-607K

123.26%643K

-6,981.82%-779K

118.87%288K

-108.09%-11K

-1,226.96%-1.53M

-70.63%136K

-161.50%-115K

132.66%463K

-58.54%187K

Operating profit

-89.04%3.49M

-12.23%50.42M

-5.49%31.83M

-6.69%57.45M

-19.51%33.68M

-7.51%61.56M

17.85%41.85M

7.41%66.56M

39.57%35.51M

-35.77%61.97M

Financing income

-70.16%154K

-47.32%856K

-68.86%516K

-84.97%1.63M

-66.29%1.66M

1,097.34%10.81M

805.34%4.92M

14.16%903K

130.08%543K

12.04%791K

Financing cost

-2.11%-4.35M

-12.17%-8.58M

-31.67%-4.26M

18.22%-7.65M

34.38%-3.24M

44.73%-9.35M

44.18%-4.93M

46.97%-16.92M

18.64%-8.84M

-11.15%-31.91M

Earning before tax

-102.52%-709K

-16.97%42.7M

-12.51%28.09M

-18.40%51.42M

-23.26%32.1M

24.69%63.02M

53.71%41.83M

63.82%50.54M

83.67%27.22M

-54.95%30.85M

Tax

100.42%33K

11.80%-11.22M

-2.89%-7.82M

6.97%-12.72M

18.90%-7.6M

-1.14%-13.68M

-30.60%-9.38M

-56.13%-13.52M

-399.58%-7.18M

53.48%-8.66M

After-tax profit from continuing operations

-103.34%-676K

-18.66%31.48M

-17.29%20.26M

-21.57%38.7M

-24.51%24.5M

33.29%49.34M

61.98%32.46M

66.82%37.02M

49.75%20.04M

-55.49%22.19M

Earning after tax

-103.34%-676K

-18.66%31.48M

-17.29%20.26M

-21.57%38.7M

-24.51%24.5M

33.29%49.34M

61.98%32.46M

66.82%37.02M

49.75%20.04M

-55.49%22.19M

Minority profit

-101.36%-3K

-16.24%325K

-6.36%221K

-2.02%388K

-16.31%236K

-1.74%396K

32.39%282K

14.81%403K

55.47%213K

-29.23%351K

Profit attributable to shareholders

-103.36%-673K

-18.69%31.15M

-17.40%20.04M

-21.73%38.31M

-24.59%24.26M

33.68%48.95M

62.30%32.17M

67.65%36.62M

49.69%19.82M

-55.76%21.84M

Basic earnings per share

-14.29%0.06

0.00%0.04

-12.50%0.07

-20.00%0.04

33.33%0.08

66.67%0.05

50.00%0.06

0.00%0.03

-63.64%0.04

Diluted earnings per share

-14.29%0.06

0.00%0.04

-12.50%0.07

-20.00%0.04

33.33%0.08

66.67%0.05

50.00%0.06

0.00%0.03

-63.64%0.04

Currency Unit

CNY

Accounting Standards

HKAS

Audit Opinions

Unqualified Opinion

Auditor

PwC

	(Q6)Jun 30, 2025	(FY)Dec 31, 2024	(Q6)Jun 30, 2024	(FY)Dec 31, 2023	(Q6)Jun 30, 2023	(FY)Dec 31, 2022	(Q6)Jun 30, 2022	(FY)Dec 31, 2021	(Q6)Jun 30, 2021	(FY)Dec 31, 2020
Turnover	-16.46%346.82M	1.08%768.73M	12.07%415.18M	4.50%760.53M	-1.14%370.47M	19.93%727.79M	30.84%374.74M	15.80%606.84M	17.07%286.4M	-1.33%524.04M
Operating income	-16.46%346.82M	1.08%768.73M	12.07%415.18M	4.50%760.53M	-1.14%370.47M	19.93%727.79M	30.84%374.74M	15.80%606.84M	17.07%286.4M	-1.33%524.04M
Cost of sales	12.38%-301.02M	-4.28%-642.03M	-14.32%-343.56M	-4.46%-615.68M	-3.21%-300.52M	-25.00%-589.39M	-33.11%-291.17M	-22.02%-471.53M	-19.60%-218.74M	-7.06%-386.45M
Operating expenses	12.38%-301.02M	-4.28%-642.03M	-14.32%-343.56M	-4.46%-615.68M	-3.21%-300.52M	-25.00%-589.39M	-33.11%-291.17M	-22.02%-471.53M	-19.60%-218.74M	-7.06%-386.45M
Gross profit	-36.05%45.8M	-12.53%126.69M	2.39%71.62M	4.66%144.84M	-16.30%69.95M	2.28%138.4M	23.51%83.57M	-1.66%135.31M	9.55%67.67M	-19.14%137.59M
Administrative expenses	-8.34%-41.91M	-5.51%-76.38M	-4.76%-38.69M	1.30%-72.39M	-4.91%-36.93M	-7.00%-73.35M	-7.93%-35.21M	3.73%-68.55M	10.68%-32.62M	3.92%-71.2M
Impairment and provision	165.31%209K	96.53%-530K	-147.34%-320K	-679.11%-15.29M	110.16%676K	-2,209.41%-1.96M	---6.65M	98.16%-85K	----	-18,340.00%-4.61M
-Other impairment is provision	165.31%209K	96.53%-530K	-147.34%-320K	-679.11%-15.29M	110.16%676K	-2,209.41%-1.96M	---6.65M	98.16%-85K	----	-18,340.00%-4.61M
Special items of operating profit	22.08%-607K	123.26%643K	-6,981.82%-779K	118.87%288K	-108.09%-11K	-1,226.96%-1.53M	-70.63%136K	-161.50%-115K	132.66%463K	-58.54%187K
Operating profit	-89.04%3.49M	-12.23%50.42M	-5.49%31.83M	-6.69%57.45M	-19.51%33.68M	-7.51%61.56M	17.85%41.85M	7.41%66.56M	39.57%35.51M	-35.77%61.97M
Financing income	-70.16%154K	-47.32%856K	-68.86%516K	-84.97%1.63M	-66.29%1.66M	1,097.34%10.81M	805.34%4.92M	14.16%903K	130.08%543K	12.04%791K
Financing cost	-2.11%-4.35M	-12.17%-8.58M	-31.67%-4.26M	18.22%-7.65M	34.38%-3.24M	44.73%-9.35M	44.18%-4.93M	46.97%-16.92M	18.64%-8.84M	-11.15%-31.91M
Earning before tax	-102.52%-709K	-16.97%42.7M	-12.51%28.09M	-18.40%51.42M	-23.26%32.1M	24.69%63.02M	53.71%41.83M	63.82%50.54M	83.67%27.22M	-54.95%30.85M
Tax	100.42%33K	11.80%-11.22M	-2.89%-7.82M	6.97%-12.72M	18.90%-7.6M	-1.14%-13.68M	-30.60%-9.38M	-56.13%-13.52M	-399.58%-7.18M	53.48%-8.66M
After-tax profit from continuing operations	-103.34%-676K	-18.66%31.48M	-17.29%20.26M	-21.57%38.7M	-24.51%24.5M	33.29%49.34M	61.98%32.46M	66.82%37.02M	49.75%20.04M	-55.49%22.19M
Earning after tax	-103.34%-676K	-18.66%31.48M	-17.29%20.26M	-21.57%38.7M	-24.51%24.5M	33.29%49.34M	61.98%32.46M	66.82%37.02M	49.75%20.04M	-55.49%22.19M
Minority profit	-101.36%-3K	-16.24%325K	-6.36%221K	-2.02%388K	-16.31%236K	-1.74%396K	32.39%282K	14.81%403K	55.47%213K	-29.23%351K
Profit attributable to shareholders	-103.36%-673K	-18.69%31.15M	-17.40%20.04M	-21.73%38.31M	-24.59%24.26M	33.68%48.95M	62.30%32.17M	67.65%36.62M	49.69%19.82M	-55.76%21.84M
Basic earnings per share	0	-14.29%0.06	0.00%0.04	-12.50%0.07	-20.00%0.04	33.33%0.08	66.67%0.05	50.00%0.06	0.00%0.03	-63.64%0.04
Diluted earnings per share	0	-14.29%0.06	0.00%0.04	-12.50%0.07	-20.00%0.04	33.33%0.08	66.67%0.05	50.00%0.06	0.00%0.03	-63.64%0.04
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS
Audit Opinions	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion
Auditor	--	PwC	--	PwC	--	PwC	--	PwC	--	PwC

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More

牛牛課堂

Oct 13, 2025 18:05

[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?

Food流油

Apr 14, 2025 15:43

"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"